pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine

BIOLOGICAL2 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions

Cervical CancerHPV DiseaseHuman PapilomavirusPrecancerous Condition

Phase 1

Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

CompletedNCT00121173

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsCervical Cancer, Precancerous Condition

Start: 2003-11-30End: 2010-01-31Updated: 2018-07-20

Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia

CompletedNCT00788164

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsCervical Cancer, HPV Disease, Human Papilomavirus +1

Start: 2008-11-30End: 2023-08-31Updated: 2023-08-31

Related Papers

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.

2021-01-1960 citations

Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination.

2018-10-056 citations

Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.

2015-09-2973 citations